Metcash Limited (ASX: MTS) – Metcash bought back $150 million, off-market

Metcash bought back - Kalkine Media

Metcash Limited (ASX: MTS) announced the successful completion of Off-Market buy back worth $150 million on 13 August 2018.

Australia’s leading wholesaler and distributor, Metcash Limited bought back 66.4 million ordinary shares at a discount of 14% to share price $2.26 per share. At an offer price of 14% discount, buyback was oversubscribed backed by the strong shareholders support resulting to which the company had to reject 72.32% shares of total 234.2 million shares tendered at discounted rates.

[optin-monster-shortcode id=”wxhmli4jjedneglg1trq”]

This oversubscription mainly accounts to franking credits benefits as buy back price of $2.26 per share includes the dividend component of $1.65 which are fully franked.

As per the announcement all the shares bought back are subject for cancellation by the company.

Settlement for buy back proceeds is scheduled for completion by 20 August 2018.

MTS share price continued to rise by 0.735% to $2.740 with the $150 million off-market buy back announcement on 13 August 2018.

Dividend Stocks To Buy

The Income available from dividends remains attractive for many investors.

We take a look at the best yields on the market and assess what they say about a company’s prospect.

One Thing is certain, though, Australia interest rates are still low, making income difficult to come by and keeping the focus for many investors on high yielding stocks. Kalkine’s team of analysts bought you handpicked report for “Top 25 Dividend Stocks For 2018.”

ASX-relevant Special Reports are published year-round to provide a detailed analysis into an investing opportunity or a potential risk to your portfolio.

Click here to get your free report.


The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.

Checkout our Free Dividend Stocks Report

Specially made for income-hungry investors, Invest in growing Franked Dividends an opportunity that should not be missed.

6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report